Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06992271 · ClinicalTrials.gov registry record · NA
Comparing Two Eccentric Protocols on Muscle Damage
A NA study of Muscle Damage and Eccentric Hypertrophy, sponsored by New York Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT06992271: Recruiting NA study of Muscle Damage and Eccentric Hypertrophy, sponsored by New York Institute of Technology.
NCT06992271 is a NA study of Muscle Damage and Eccentric Hypertrophy that is actively recruiting participants, run by New York Institute of Technology. The registered enrollment target is 16 participants, below the 42-participant average among 6 other Muscle Damage trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06992271, a NA study of Muscle Damage and Eccentric Hypertrophy, is actively recruiting participants, sponsored by New York Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study will be to test whether a new way of weight training is more effective than typical weight training. The investigators expect that this new way will cause more exercise-induced muscle damage, which helps people build bigger muscles. Another purpose of this study will be to explore perceptions of how muscle soreness impacts participant activities of daily living.
Primary Outcome
Visual analog scale as indirect indicator of muscle damage. Scale of 1-5. Higher score = more soreness
Conditions Studied
Interventions
- BEHAVIORAL Fast Eccentric
- BEHAVIORAL Slow Eccentric
Study Locations (1)
New York
- NYIT - Old Westbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-03-08 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
What NCT06992271 shows while recruiting
NCT06992271 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 42-participant average among 6 other Muscle Damage trials with a reported enrollment target (62% lower).
The record links to 2 conditions, with Muscle Damage appearing as the primary indexed condition, and to 2 interventions - of which Fast Eccentric is the first listed.
NCT06992271 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06992271 about?
NCT06992271 is a clinical study titled "Comparing Two Eccentric Protocols on Muscle Damage". The purpose of this study will be to test whether a new way of weight training is more effective than typical weight training. The investigators expect that this new way will cause more exercise-induced muscle damage, which helps people build bigger muscles. Another purpose of this study will be to ...
What is the current status of trial NCT06992271?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2023-03-08. Estimated completion is 2025-06-01.
What conditions does trial NCT06992271 study?
This clinical trial studies the following conditions: Muscle Damage, Eccentric Hypertrophy.
What interventions are being tested in trial NCT06992271?
The interventions under investigation include: Fast Eccentric (BEHAVIORAL), Slow Eccentric (BEHAVIORAL).
Who is sponsoring clinical trial NCT06992271?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06992271 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Damage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery
RECRUITING · NA
-
Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise
RECRUITING · NA
-
HIFEM and Radiofrequency for Muscular System Function Improvement
ACTIVE NOT RECRUITING · NA
-
Protein and Recovery From Exercise-induced Muscle Damage
COMPLETED · NA
-
Comparison of Pre-exercise Beta-hydroxy-beta-methylbutyrate Free Acid (HMB-FA) and Cold Water Therapy for the Attenuation of Muscle Damage and Soreness
COMPLETED · NA
-
The Long-term Effects of Oceanix™ on Resistance Training Adaptations
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI